Ian F. Smith

2007

In 2007, Ian F. Smith earned a total compensation of $3.4M as Executive Vice President and Chief Financial Officer at Vertex Pharmaceuticals, a 76% increase compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$141,907
Option Awards$1,641,900
Salary$411,595
Stock Awards$1,164,328
Other$12,543
Total$3,372,273

Smith received $1.6M in option awards, accounting for 49% of the total pay in 2007.

Smith also received $141.9K in non-equity incentive plan, $411.6K in salary, $1.2M in stock awards and $12.5K in other compensation.

Rankings

In 2007, Ian F. Smith's compensation ranked 1,320th out of 8,700 executives tracked by ExecPay. In other words, Smith earned more than 84.8% of executives.

ClassificationRankingPercentile
All
1,320
out of 8,700
85th
Division
Manufacturing
469
out of 3,314
86th
Major group
Chemicals And Allied Products
85
out of 746
89th
Industry group
Drugs
50
out of 546
91st
Industry
Pharmaceutical Preparations
39
out of 364
89th
Source: SEC filing on April 15, 2010.

Smith's colleagues

We found four more compensation records of executives who worked with Ian F. Smith at Vertex Pharmaceuticals in 2007.

2007

Joshua Boger

Vertex Pharmaceuticals

Chief Executive Officer

2007

Peter Mueller

Vertex Pharmaceuticals

Chief Scientific Officer

2007

Kenneth Boger

Vertex Pharmaceuticals

General Counsel

2007

Kurt Graves

Vertex Pharmaceuticals

Executive Vice President, Chief Commercial Officer and Head, Strategic Development

News

You may also like